OTC & Nutraceuticals Mexico

Mexico Weight Management Supplements Market Analysis, 2024–2034

Mexico Weight Management Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Mexico · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $524.7 Mn Estimated value
Estimate 2025 $561.5 Mn 1.5% of the global market
Projected 2034 $1.03 Bn 83.8% Adds $470.8 Mn over 9 forecast years
CAGR 2025–2034 7.0% Faster than 44% of 82 OTC & Nutraceuticals markets here
Key players 5
  • Mexico is 1.49% of the global market.
  • In Latin America, the largest is Brazil at $970.9 Mn.
  • Fastest growing: Brazil at 8.2% a year.
  • Mexico ranks 3rd of 3 by size in Latin America.

Market size projection

Mexico

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$470.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Weight Management Supplements Market market size by year, Mexico
YearMarket sizeChange that yearSince 2025
2024 (estimate) $524.7 Mn — —
2025 (base) $561.5 Mn +$36.7 Mn —
2026 (forecast) $600.8 Mn +$39.3 Mn +7%
2027 (forecast) $642.8 Mn +$42.1 Mn +14.5%
2028 (forecast) $687.8 Mn +$45.0 Mn +22.5%
2029 (forecast) $736.0 Mn +$48.1 Mn +31.1%
2030 (forecast) $787.5 Mn +$51.5 Mn +40.3%
2031 (forecast) $842.6 Mn +$55.1 Mn +50.1%
2032 (forecast) $901.6 Mn +$59.0 Mn +60.6%
2033 (forecast) $964.7 Mn +$63.1 Mn +71.8%
2034 (forecast) $1.03 Bn +$67.5 Mn +83.8%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

The Mexico Weight Management Supplements Market Analysis Executive Summary

Weight management supplements are capsules, powders and drinks that claim to support fat loss, appetite control or metabolism.

Key segments of the weight Management Supplements market include ingredient (Green Tea Extract, Fibers and Protein) and form (Capsules and Tablets, Powders and Ready-to-Drink).

Mexico Weight Management Supplements Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the weight Management Supplements market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the weight Management Supplements market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the weight Management Supplements market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Weight Management Supplements Market in Mexico

The weight Management Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Weight Management Supplements Market in Mexico

Policy changes and Reimbursement scenario

Food and supplement rules, labelling and health-claim regulations govern weight Management Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in Mexico.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Weight Management Supplements right now, from free public sources.

Clinical trials

56 active trials in Mexico

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Novo Nordisk A/S 59 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Eli Lilly and Company 58 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Pfizer Inc. 20 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Amgen Inc. 18 active trials on ClinicalTrials.gov (opens in a new tab)
  5. AstraZeneca 13 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Weight Management Supplements in context

Mexico compared

  • Obesity (adults): 37.4% of adults (2024). World: 16.2% of adults (2024). Highest of the 4 countries we cover in Latin America.[1]
  • Health spending per person: 761 US$ per person (2023). World: 1,317 US$ per person (2023). 2nd highest of the 4 countries we cover in Latin America.[2]
  • Doctors: 2.59 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 4 countries we cover in Latin America.[3]

Questions, answered with public data

How many clinical trials on Weight Management Supplements are running in Mexico?
56 studies are recruiting, active or about to start in Mexico.[4]
How much research is published on Weight Management Supplements?
PubMed lists 342 papers added since January 2021 that match this market, worldwide.[5]
What does WHO report for Mexico?
Obesity (adults): 37.4 % of adults in 2024, the latest WHO figure.[1]
How many people in Mexico are 65 or older?
8.5% of people were 65 or older in 2025.[6]

[1] WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Mexico. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

[6] World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 13 Nov 2026.

Free data on this topic

Back to Catalogue

Related OTC & Nutraceuticals reports in Mexico

See all

Related on obesity and nutrition

See the topic